Storebrand Grön Obligation A SEK vs UBS Lux Equity Fund Biotech USD

Storebrand Grön Obligation A SEK vs UBS Lux Equity Fund Biotech USD

1. Storebrand Grön Obligation A SEK

  • Security

    Storebrand Grön Obligation A SEK

  • Fee

    0.31%

  • ISIN

    SE0006763967

  • Holdings

    5

  • Number of owning funds

    1

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 6 holdings in Storebrand Grön Obligation A SEK, where the largest holding is Stadshypotek (3.64), followed by Jernhusen (1.56) and Region Skåne (1.4). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Storebrand Grön Obligation A SEK and UBS Lux Equity Fund Biotech USD.

Storebrand Grön Obligation A SEK UBS Lux Equity Fund Biotech USD
1. Stadshypotek AB
Sweden
3.64 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Jernhusen AB
Sweden
1.56 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Region Skåne
Sweden
1.4 %
3. Moderna Inc
9.21 %
4. Ziklo Bank AB
Sweden
1.35 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Humlegården Fastigheter AB
Sweden
1.35 %
5. AbbVie Inc
USA
5.53 %
- 6. Gilead Sciences Inc
USA
4.66 %
- 7. Amgen Inc
4.3 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.37 %

The list of fund holdings was last updated on June 6, 2025.